North Hollywood, California Clinical Trials

A listing of North Hollywood, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 71 clinical trials
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

crizotinib
cataract
measurable disease
neutrophil count
multiple meningiomas
Univ of California @ Los Angeles (Site 325)
 (6.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +16 other locations
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

This early phase I trial studies how well a behavioral weight loss intervention consisting of a smartphone application and coaching works for the promotion of weight loss in adolescents and young adults after a stem cell transplant. This study may help researchers learn more about how adolescents and young adults …

body mass index
stem cell transplantation
weight control
hematopoietic stem cell transplantation
cancer
UCLA / Jonsson Comprehensive Cancer Center
 (8.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD)

atrophy
maculopathy
age-related macular degeneration
complement c5
macular degeneration
Retina-Vitreous Associates Medical Group
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +22 other locations
Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy

This is a Phase 1, open-label, dose escalation study aimed at evaluating the safety, early efficacy and potential biomarkers of (+)-epicatechin in patients with Becker or Becker-like Muscular Dystrophy (BMD).

UCLA Dept of Human Genetics
 (8.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

regurgitation
aortic valve replacement
fatigue
shortness of breath
Cedars Sinai Medical Center
 (7.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

prostatic neoplasms, castration-resistant
castration-resistant prostate cancer
measurable disease
cancer
taxane
The University of California, Los Angeles
 (6.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
Changes in Cellular Immune Profile During COVID-19 Infection

Clinical specimens are collected from individuals either recovered from or with active SARS-CoV-2 infection to support process and analytical development for a potential cell-based immunotherapy in preclinical research, SRPH-CVD-01. SRPH-CVD-01 is an allogeneic cell-based immunotherapy candidate to be investigated in a subsequent clinical trial under a future FDA IND to …

gene therapy
covid-19
SARS
infection clinical
leukapheresis
Seraph Research Institute
 (9.1 away) Contact site
  • 0 views
  • 01 Feb, 2023
  • 1 location
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

eliglustat
imiglucerase
gaucher disease
deficiency
Investigational Site Number 840108
 (6.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +208 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840108
 (6.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +124 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

replacement therapy
myozyme
deficiency
gaa gene
glycogen storage disease type ii
Investigational Site Number 840108
 (6.7 away) Contact site
  • 0 views
  • 22 Dec, 2020
  • +168 other locations